Why a Buyout Deal May Not Be in the Cards for Acadia Post author:Sam Post published:November 27, 2017 Post category:BioPharma A look at why a potential buyout of Acadia might not be as likely as some have suggested. Source: BioSpace You Might Also Like 26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017 Biogen Release: Company Reports 2016 Revenues Of $11.4 Billion January 25, 2017 3 Intriguing Small-Cap Biotechs to Put on Your Watchlist April 19, 2017
26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017